NO991235L - Forbindelser anvendelige for inhibering av farnesylproteintransferase - Google Patents
Forbindelser anvendelige for inhibering av farnesylproteintransferaseInfo
- Publication number
- NO991235L NO991235L NO991235A NO991235A NO991235L NO 991235 L NO991235 L NO 991235L NO 991235 A NO991235 A NO 991235A NO 991235 A NO991235 A NO 991235A NO 991235 L NO991235 L NO 991235L
- Authority
- NO
- Norway
- Prior art keywords
- protein transferase
- inhibition
- farnesyl protein
- compounds useful
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71329796A | 1996-09-13 | 1996-09-13 | |
| US87745397A | 1997-06-17 | 1997-06-17 | |
| PCT/US1997/019976 WO1998011091A2 (en) | 1996-09-13 | 1997-09-11 | Tricyclic compounds useful for inhibition of farnesyl protein transferase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO991235D0 NO991235D0 (no) | 1999-03-12 |
| NO991235L true NO991235L (no) | 1999-05-10 |
Family
ID=27108965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO991235A NO991235L (no) | 1996-09-13 | 1999-03-12 | Forbindelser anvendelige for inhibering av farnesylproteintransferase |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0934303B1 (de) |
| JP (1) | JP2001500515A (de) |
| KR (1) | KR20000036110A (de) |
| CN (1) | CN1237164A (de) |
| AT (1) | ATE286044T1 (de) |
| AU (1) | AU5196698A (de) |
| BR (1) | BR9712980A (de) |
| CA (1) | CA2266014A1 (de) |
| CZ (1) | CZ84599A3 (de) |
| DE (1) | DE69732123T2 (de) |
| ES (1) | ES2234036T3 (de) |
| ID (1) | ID21577A (de) |
| IL (1) | IL128951A0 (de) |
| NO (1) | NO991235L (de) |
| NZ (1) | NZ334454A (de) |
| PL (1) | PL332192A1 (de) |
| SK (1) | SK33699A3 (de) |
| TR (1) | TR199901275T2 (de) |
| WO (1) | WO1998011091A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
| WO1998057948A1 (en) * | 1997-06-17 | 1998-12-23 | Schering Corporation | Novel n-substituted urea inhibitors of farnesyl-protein transferase |
| US6358968B1 (en) | 1997-06-17 | 2002-03-19 | Schering Corporation | N-substituted urea inhibitors of farnesyl-protein transferase |
| US5939416A (en) * | 1997-06-17 | 1999-08-17 | Schering Corporation | Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
| CA2336448A1 (en) | 1998-07-02 | 2000-01-13 | Christopher J. Dinsmore | Inhibitors of prenyl-protein transferase |
| CA2336054A1 (en) | 1998-07-02 | 2000-01-13 | Merck And Co., Inc. | Inhibitors of prenyl-protein transferase |
| US6316462B1 (en) * | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
| WO2001051128A1 (en) | 2000-01-12 | 2001-07-19 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| AU2001229320A1 (en) | 2000-01-12 | 2001-07-24 | Merck And Co., Inc. | Inhibitors of prenyl-protein transferase |
| US6566385B2 (en) | 2000-01-12 | 2003-05-20 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| US6610722B2 (en) | 2000-04-10 | 2003-08-26 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826853A (en) * | 1986-10-31 | 1989-05-02 | Schering Corporation | 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use |
| US5089496A (en) * | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
| JPH0676403B2 (ja) * | 1991-01-18 | 1994-09-28 | エスエス製薬株式会社 | 新規なベンゾ［５，６ シクロヘプタ［１，２−ｂ ピリジン誘導体及びこれを含有する抗アレルギー剤 |
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| DE69429440T2 (de) * | 1993-10-15 | 2002-08-08 | Schering Corp., Kenilworth | Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen |
| ES2164716T3 (es) * | 1993-10-15 | 2002-03-01 | Schering Corp | Compuestos triciclicos de carbamato utiles para inhibir la funcion de la proteina-g y para el tratamiento de enfermedades proliferativas. |
| US5719148A (en) * | 1993-10-15 | 1998-02-17 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| US5700806A (en) * | 1995-03-24 | 1997-12-23 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| EP1019392B1 (de) * | 1995-12-22 | 2005-11-09 | Schering Corporation | Zur hemming der g-protein-funktion und zur behandlung proliferativer krankheiten geeignete tricyclische amide |
-
1997
- 1997-09-11 TR TR1999/01275T patent/TR199901275T2/xx unknown
- 1997-09-11 CA CA002266014A patent/CA2266014A1/en not_active Abandoned
- 1997-09-11 WO PCT/US1997/019976 patent/WO1998011091A2/en active IP Right Grant
- 1997-09-11 BR BR9712980-1A patent/BR9712980A/pt unknown
- 1997-09-11 ID IDW990085A patent/ID21577A/id unknown
- 1997-09-11 NZ NZ334454A patent/NZ334454A/xx unknown
- 1997-09-11 ES ES97946875T patent/ES2234036T3/es not_active Expired - Lifetime
- 1997-09-11 PL PL97332192A patent/PL332192A1/xx unknown
- 1997-09-11 KR KR1019997002133A patent/KR20000036110A/ko not_active Application Discontinuation
- 1997-09-11 CZ CZ99845A patent/CZ84599A3/cs unknown
- 1997-09-11 EP EP97946875A patent/EP0934303B1/de not_active Expired - Lifetime
- 1997-09-11 DE DE69732123T patent/DE69732123T2/de not_active Expired - Lifetime
- 1997-09-11 AU AU51966/98A patent/AU5196698A/en not_active Abandoned
- 1997-09-11 SK SK336-99A patent/SK33699A3/sk unknown
- 1997-09-11 JP JP10514032A patent/JP2001500515A/ja not_active Ceased
- 1997-09-11 AT AT97946875T patent/ATE286044T1/de not_active IP Right Cessation
- 1997-09-11 CN CN97199597A patent/CN1237164A/zh active Pending
- 1997-09-11 IL IL12895197A patent/IL128951A0/xx unknown
-
1999
- 1999-03-12 NO NO991235A patent/NO991235L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69732123T2 (de) | 2005-12-08 |
| WO1998011091A3 (en) | 1998-06-11 |
| IL128951A0 (en) | 2000-02-17 |
| ID21577A (id) | 1999-06-24 |
| WO1998011091A2 (en) | 1998-03-19 |
| EP0934303B1 (de) | 2004-12-29 |
| EP0934303A2 (de) | 1999-08-11 |
| PL332192A1 (en) | 1999-08-30 |
| CA2266014A1 (en) | 1998-03-19 |
| KR20000036110A (ko) | 2000-06-26 |
| CZ84599A3 (cs) | 1999-07-14 |
| BR9712980A (pt) | 2000-04-18 |
| ES2234036T3 (es) | 2005-06-16 |
| TR199901275T2 (xx) | 1999-09-21 |
| DE69732123D1 (de) | 2005-02-03 |
| SK33699A3 (en) | 2000-03-13 |
| NO991235D0 (no) | 1999-03-12 |
| ATE286044T1 (de) | 2005-01-15 |
| AU5196698A (en) | 1998-04-02 |
| NZ334454A (en) | 2000-08-25 |
| CN1237164A (zh) | 1999-12-01 |
| JP2001500515A (ja) | 2001-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991234D0 (no) | Trisykliske inhibitorer av farnesylproteintransferase | |
| NO991235L (no) | Forbindelser anvendelige for inhibering av farnesylproteintransferase | |
| NO991229D0 (no) | Substituerte benzosykloheptapyridinderivater for inhibering av farnesylproteintransferase | |
| NO991231D0 (no) | Forbindelser for inhibering av farnesylproteintransferase | |
| NO991232D0 (no) | Substituerte benzosykloheptapyridinderivater anvendelige for inhibering av farnesylproteintransferase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |